RxDoctor Payments Data

Paayal Patel

Neurology · West Palm Beach, FLNPI 1659501211

Payments from drug & device makers

What this record shows

6 manufacturers reported payments, led by Janssen Research & Development, LLC at 28.6% of the total. Reporting peaked in 2024 at $2,466 and has fallen 97.4% since, to $64 in 2025.

$3,301in general payments, 2019–2025

Across 34 payments — averaging $97.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$945
  • E.r. Squibb & Sons, L.L.C.$773
  • Merck$703
  • Eisai Inc.$651
  • Biogen$185
  • Medtronic$43
$17,320,298in research payments, 2019–2025

Across 793 payments — averaging $21,841 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$13.4M
  • Biogen$1.3M
  • Eisai Inc.$848K
  • Janssen Research & Development, LLC$584K
  • Novo Nordisk AS$306K
  • GSK$298K
  • plus $604K from 5 others

What the payments were for

  • Travel & lodging$1,95759%
  • Food & beverage$1,34441%

General payments by program year

19
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,301 in reported general payments places this provider in the 55th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida

Other neurology in West Palm Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →